Abstract:Circulation Research, Volume 134, Issue 12, Page 1718-1751, June 7, 2024. The adult mammalian heart has limited endogenous regenerative capacity and heals through the activation of inflammatory and fibrogenic cascades that ultimately result in the formation of a scar. After infarction, massive cardiomyocyte death releases a broad range of damage-associated molecular patterns that initiate both myocardial and systemic inflammatory responses. TLRs (toll-like receptors) and NLRs (NOD-like receptors) recognize damage-associated molecular patterns (DAMPs) and transduce downstream proinflammatory signals, leading to upregulation of cytokines (such as interleukin-1, TNF-α [tumor necrosis factor-α], and interleukin-6) and chemokines (such as CCL2 [CC chemokine ligand 2]) and recruitment of neutrophils, monocytes, and lymphocytes. Expansion and diversification of cardiac macrophages in the infarcted heart play a major role in the clearance of the infarct from dead cells and the subsequent stimulation of reparative pathways. Efferocytosis triggers the induction and release of anti-inflammatory mediators that restrain the inflammatory reaction and set the stage for the activation of reparative fibroblasts and vascular cells. Growth factor–mediated pathways, neurohumoral cascades, and matricellular proteins deposited in the provisional matrix stimulate fibroblast activation and proliferation and myofibroblast conversion. Deposition of a well-organized collagen-based extracellular matrix network protects the heart from catastrophic rupture and attenuates ventricular dilation. Scar maturation requires stimulation of endogenous signals that inhibit fibroblast activity and prevent excessive fibrosis. Moreover, in the mature scar, infarct neovessels acquire a mural cell coat that contributes to the stabilization of the microvascular network. Excessive, prolonged, or dysregulated inflammatory or fibrogenic cascades accentuate adverse remodeling and dysfunction. Moreover, inflammatory leukocytes and fibroblasts can contribute to arrhythmogenesis. Inflammatory and fibrogenic pathways may be promising therapeutic targets to attenuate heart failure progression and inhibit arrhythmia generation in patients surviving myocardial infarction.

View from the heart: cardiac fibroblasts in development, scarring and regeneration

Role of Cardiac Fibroblasts in Cardiac Injury and Repair

Direct Reprogramming of Cardiac Fibroblasts to Repair the Injured Heart

Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction

Characterization of cardiac fibroblast-extracellular matrix crosstalk across developmental ages provides insight into age-related changes in cardiac repair

Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities

Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies

Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease

Can we remove scar and fibrosis from adult human myocardium?

Cardiac fibrosis.

Leading Progress in Heart Regeneration and Repair

Myofibroblasts and Fibrosis

Origin and Function of Activated Fibroblast States During Zebrafish Heart Regeneration.

Repair Injured Heart by Regulating Cardiac Regenerative Signals

Novel Techniques Targeting Fibroblasts after Ischemic Heart Injury

Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling

The adaptive immune response to cardiac injury—the true roadblock to effective regenerative therapies?

Spatio-temporal dynamics of the fibrotic niche in cardiac repair

Mechanoregulation of Cardiac Myofibroblast Differentiation: Implications for Cardiac Fibrosis and Therapy

Cardiac fibroblasts and mechanosensation in heart development, health and disease

Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair